Dr Suresh Muthukumaraswamy - how psychedelics break the research mold Artwork

A Brave New Mind - Psychedelic Medicine in Aotearoa

Psychedelic medicine is on its way to Aotearoa, and we're taking you on the journey. Join us each week as we ask the big questions, and ponder the potentials and pitfalls of this burgeoning field with local scientists and researchers, the big overseas names in the field, Kiwi clinicians, those gearing up to take therapeutic psychedelics into the mainstream, and more.

All Episodes

A Brave New Mind - Psychedelic Medicine in Aotearoa

Dr Suresh Muthukumaraswamy - how psychedelics break the research mold

October 14, 2020 • Dr Will Evans and Susi Maclean • Season 1 • Episode 3

0:00 | 54:10

Our chat with Dr Suresh Muthukumaraswamy took us down the kind of rabbit-hole that's becoming all too familiar as we continue our exploration of psychedelics as medicine. Despite - or because of - all the twists and turns it was an invigorating and thought provoking conversation, even if we did just scratch the surface of some of the perplexities and complexities of working with these medicines.

Suresh is a neuroscientist and associate professor in the School of Pharmacy at the University of Auckland, has done groundbreaking research on psilocybin, LSD and ketamine here and at Imperial College London, and along with Will and others, is about to start one of the world's first LSD microdosing trials.